APA
Dirschka T., Radny P., Dominicus R., Mensing H., Brüning H., Jenne L., Karl L., Sebastian M., Oster-Schmidt C., Klövekorn W., Reinhold U., Tanner M., Gröne D., Deichmann M., Simon M., Hübinger F., Hofbauer G., Krähn-Senftleben G., Borrosch F., Reich K., Berking C., Wolf P., Lehmann P., Moers-Carpi M., Hönigsmann H., Wernicke-Panten K., Hahn S., Pabst G., Voss D., Foguet M., Schmitz B., Lübbert H. & Szeimies R. (20130919). Long-term (6 and 12 months) follow-up of two prospective, randomized, controlled phase III trials of photodynamic therapy with BF-200 ALA and methyl aminolaevulinate for the treatment of actinic keratosis. : The British journal of dermatology.
Chicago
Dirschka T, Radny P, Dominicus R, Mensing H, Brüning H, Jenne L, Karl L, Sebastian M, Oster-Schmidt C, Klövekorn W, Reinhold U, Tanner M, Gröne D, Deichmann M, Simon M, Hübinger F, Hofbauer G, Krähn-Senftleben G, Borrosch F, Reich K, Berking C, Wolf P, Lehmann P, Moers-Carpi M, Hönigsmann H, Wernicke-Panten K, Hahn S, Pabst G, Voss D, Foguet M, Schmitz B, Lübbert H and Szeimies R-M. 20130919. Long-term (6 and 12 months) follow-up of two prospective, randomized, controlled phase III trials of photodynamic therapy with BF-200 ALA and methyl aminolaevulinate for the treatment of actinic keratosis. : The British journal of dermatology.
Harvard
Dirschka T., Radny P., Dominicus R., Mensing H., Brüning H., Jenne L., Karl L., Sebastian M., Oster-Schmidt C., Klövekorn W., Reinhold U., Tanner M., Gröne D., Deichmann M., Simon M., Hübinger F., Hofbauer G., Krähn-Senftleben G., Borrosch F., Reich K., Berking C., Wolf P., Lehmann P., Moers-Carpi M., Hönigsmann H., Wernicke-Panten K., Hahn S., Pabst G., Voss D., Foguet M., Schmitz B., Lübbert H. and Szeimies R. (20130919). Long-term (6 and 12 months) follow-up of two prospective, randomized, controlled phase III trials of photodynamic therapy with BF-200 ALA and methyl aminolaevulinate for the treatment of actinic keratosis. : The British journal of dermatology.
MLA
Dirschka T, Radny P, Dominicus R, Mensing H, Brüning H, Jenne L, Karl L, Sebastian M, Oster-Schmidt C, Klövekorn W, Reinhold U, Tanner M, Gröne D, Deichmann M, Simon M, Hübinger F, Hofbauer G, Krähn-Senftleben G, Borrosch F, Reich K, Berking C, Wolf P, Lehmann P, Moers-Carpi M, Hönigsmann H, Wernicke-Panten K, Hahn S, Pabst G, Voss D, Foguet M, Schmitz B, Lübbert H and Szeimies R-M. Long-term (6 and 12 months) follow-up of two prospective, randomized, controlled phase III trials of photodynamic therapy with BF-200 ALA and methyl aminolaevulinate for the treatment of actinic keratosis. : The British journal of dermatology. 20130919.